Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 8, 2016
Current issues concerning drug development for pediatric hematologic malignanciesMasahiro Sekimizu[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|October 12, 2018
[Therapeutic approaches to hematological malignancies in adolescents and young adults]Masahiro Sekimizu[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|September 9, 2017
Malignant lymphoma of adolescents and young adults: from the viewpoint of pediatriciansRyoji Kobayashi, Masahiro Sekimizu[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 17, 2013
[Analysis of thyroid lesions in childhood recipients after hematopoietic stem cell transplantation]Naoko Maeda, Takashi Hamajima, Yuko Yambe, et al.Journal of Pediatric Hematology/Oncology|September 22, 2012
Osteosarcoma after bone marrow transplantationHideaki Ueki, Naoko Maeda, Masahiro Sekimizu, et al.Journal of Pediatric Hematology/Oncology|December 11, 2013
A case of NUT midline carcinoma with complete response to gemcitabine following cisplatin and docetaxelHideaki Ueki, Naoko Maeda, Masahiro Sekimizu, et al.Pediatric Blood & Cancer|April 12, 2018
Efficacy and safety of administering pediatric treatment to adolescent patients with mature B-cell non-Hodgkin lymphoma within the Japanese Pediatric Leukemia/Lymphoma Study Group clinical trialMasahiro Sekimizu, Hiroya Hashimoto, Tetsuya Mori, et al.Acta Medica Okayama|August 25, 2018
Phase II Clinical Trial for Newly Diagnosed Children and Adolescents with Localized Lymphoblastic Lymphoma (Japanese Leukemia/Lymphoma Study Group Trial LLB-NHL03) : Study Protocol for Nationwide Multicenter TrialMasahiro Sekimizu, Junichiro Fujimoto, Tetsuya Takimoto, et al.BMC Cancer|February 3, 2018
Phase I clinical study of brentuximab vedotin (SGN-35) involving children with recurrent or refractory CD30-positive Hodgkin's lymphoma or systemic anaplastic large cell lymphoma: rationale, design and methods of BV-HLALCL study: study protocolMasahiro Sekimizu, Akihiro Iguchi, Tetsuya Mori, et al.Nagoya Journal of Medical Science|September 8, 2017
Phase II trial of CH5424802 (alectinib hydrochloride) for recurrent or refractory ALK-positive anaplastic large cell lymphoma: study protocol for a non-randomized non-controlled trialHirokazu Nagai, Reiji Fukano, Masahiro Sekimizu, et al.Pageof 5